Access cutting-edge chronic migraine treatment through this clinical trial at a research site in Naperville. Study-provided care at no cost to qualified participants.
Access chronic migraine specialists in Naperville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic migraine treatment provided free
The purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks. Rimegepant is a tablet that dissolves when you put it on or under your tongue. The study will enroll participants who have headache for 15 days (or more) every month, of which 8 days (or more) of migraine every month, and each untreated attack lasts for an average of 4-72 hours In the 1st part of the study approximately half of the participants will r
Sponsor: Pfizer
Check if you qualify for this chronic migraine clinical trial in Naperville, IL
If you're searching for chronic migraine treatment options in Naperville, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Naperville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.